Biohaven Pharmaceutical Holding Company Ltd BHVN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
97.27UNCH (UNCH)
Volume
14,781
Close
97.27quote price arrow down-0.45 (-0.46%)
Volume
529,926
52 week range
57.66 - 106.56

...

Loading . . .
  • Open98.53
  • Day High99.40
  • Day Low97.10
  • Prev Close97.72
  • 52 Week High106.56
  • 52 Week High Date06/11/21
  • 52 Week Low57.66
  • 52 Week Low Date08/11/20

Key Stats

  • Market Cap6.329B
  • Shares Out65.07M
  • 10 Day Average Volume1.15M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change13.49

KEY STATS

  • Open98.53
  • Day High99.40
  • Day Low97.10
  • Prev Close97.72
  • 52 Week High106.56
  • 52 Week High Date06/11/21
  • 52 Week Low57.66
  • 52 Week Low Date08/11/20
  • Market Cap6.329B
  • Shares Out65.07M
  • 10 Day Average Volume1.15M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change13.49

RATIOS/PROFITABILITY

  • EPS (TTM)-14.25
  • P/E (TTM)-6.83
  • Fwd P/E (NTM)-8.71
  • EBITDA (MRQ)-714.892M
  • ROE (MRQ)-805.56%
  • Revenue (MRQ)106.30M
  • Gross Margin (MRQ)71.65%
  • Net Margin (MRQ)-809.99%
  • Debt To Equity (MRQ)-265.20%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biohaven Pharmaceutical Holding Company Ltd

Profile

MORE
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The Company's glutamate platform includes three clinical-stage product candidates being developed for the treatment of various neurological indications: trigriluzole for the treatment of obsessive-compulsive disorder (OCD), spinocerebellar...
Declan Doogan M.D.
Chairman
Vlad Coric M.D.
Chief Executive Officer
James Engelhart CPA
Chief Financial Officer
Address
215 Church St
New Haven, CT
06510-1803
United States

Top Peers

SYMBOLLASTCHG%CHG
VIR
Vir Biotechnology Inc
49.59+2.49+5.29%
PACB
Pacific Biosciences of California Inc
32.48+1.08+3.44%
ADPT
Adaptive Biotechnologies Corp
40.27-0.69-1.68%
TWST
Twist Bioscience Corp
122.54+2.40+2.00%
NTLA
Intellia Therapeutics Inc
86.84+3.25+3.89%